Shares Of Micro Cap Biotech Surging On Acquisition Of Exclusive Worldwide Rights to Phase III TLR5 Agonist
13 2월 2025 - 12:40AM
AllPennyStocks.com
Today was a big day for one small cap biotech
company. The company announced that they had acquired worldwide
exclusive license rights to a late-stage Toll-like Receptor 5
(TLR5)...
To read the full story on AllPennyStocks.com, click
here.
Statera BioPharma (NASDAQ:STAB)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Statera BioPharma (NASDAQ:STAB)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
